VVOS

Vivos Therapeutics, Inc.

2.24 USD
-0.02 (-0.88%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vivos Therapeutics, Inc. stock is down -17.65% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 May’s closed higher than April.

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada.